Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes
André Scheen
Topics & Concepts
DulaglutideGlucagon-like peptide 1 receptorSemaglutideType 2 diabetesMedicineLiraglutideExenatideInternal medicineEndocrinologyPharmacologyAgonistGlucagon-like peptide-1Diabetes mellitusReceptorDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPharmacology and Obesity Treatment